Lancet Reports New Positive Cardio, Metabolic Data for Vivus’ Qnexa
Donna Young donna.young@informa.com A study published in the Lancet reported new cardiovascular, metabolic and inflammatory disease details from a Phase III study of Vivus’ investigational weight loss...
View ArticleScrip Awards 2011 – Shortlist Announced – Are You In?
The Scrip Awards provides the industry an opportunity to acknowledge and applaud its highest achievers across all parts of the value chain, and recognise both corporate and individual achievement. Over...
View ArticleBiogen Idec’s BG-12 Shines At the Top of the Charts in the Treatment of...
BG-12 Beats Teva’s Copaxone in Biogen Idec’s CONFIRM Trial Citeline, an Informa business unit, and the world’s leading research authority on pharmaceutical clinical trials recently reviewed results...
View ArticleClik here to view.
Analysis of clinical trial results presented at ASH 2011
The 53rd Annual American Society of Hematology Meeting and Exposition (ASH 2011) was held on December 10-13 in San Diego, CA. In this report, Citeline Analytics provides an overview of the clinical...
View ArticleClik here to view.
The Landscape of Female Sexual Dysfunction Treatment
Doro Shin, MPH, Citeline Analyst, Infectious & Genitourinary Diseases Sexual dysfunction is defined as a disturbance in or pain during the sexual response and can present in various ways. This...
View ArticleClik here to view.
Outlook for Obesity Drugs – Companies weighing risks and rewards of drug...
Robin Custeau, MS, Analyst, Cardiovascular & Metabolic/Endocrinology According to the World Health Organization (WHO), lifestyle related non-communicable diseases are the leading cause of death...
View ArticleCompanion Diagnostics: A Rocky Road Ahead?
Gabrielle Gessner, Citeline Senior Analyst, Infectious & Genitourinary Diseases Companion diagnostic pairs are emerging as the new face of personalized medicine, allowing treatment decisions to be...
View Article$66m PE investment in Indian diagnostics chain amid sectoral promise
Indian diagnostics chain Super Religare Laboratories (SRL) is set to receive a capital injection of Rs3.70bn ($66.3m) from private equity fund, NYLIM Jacob Ballas India Fund, and the World Bank arm,...
View ArticleGSK launches first dose-counting inhaler in India, but domestic competition...
GlaxoSmithKline Pharmaceuticals has introduced in India an enhanced version of a metered dose inhaler (MDI) with a dose counter, the first of its kind in the country, although a clutch of domestic...
View ArticleNext steps in healthcare big data: what, why and how
Big data is at the very heart of the next major innovation wave in healthcare that has the potential to bring about productivity gains and increase cost efficiencies to the provider, facilitate...
View Article
